These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 9766814)

  • 1. Cell-surface antigen expression in early and term gestation fetal hematopoietic progenitor cells.
    Opie TM; Shields LE; Andrews RG
    Stem Cells; 1998; 16(5):343-8. PubMed ID: 9766814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood.
    Huang S; Law P; Young D; Ho AD
    Exp Hematol; 1998 Nov; 26(12):1162-71. PubMed ID: 9808056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal development of human fetal hematopoiesis between eight and seventeen weeks' gestation.
    Pahal GS; Jauniaux E; Kinnon C; Thrasher AJ; Rodeck CH
    Am J Obstet Gynecol; 2000 Oct; 183(4):1029-34. PubMed ID: 11035358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly efficient gene transfer into preterm CD34 hematopoietic progenitor cells.
    Shields LE; Kiem HP; Andrews RG
    Am J Obstet Gynecol; 2000 Sep; 183(3):732-7. PubMed ID: 10992201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensive amplification of single cells from CD34+ subpopulations in umbilical cord blood and identification of long-term culture-initiating cells present in two subsets.
    de Wynter EA; Nadali G; Coutinho LH; Testa NG
    Stem Cells; 1996 Sep; 14(5):566-76. PubMed ID: 8888497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional differences between subpopulations of mobilized peripheral blood-derived CD34+ cells expressing different levels of HLA-DR, CD33, CD38 and c-kit antigens.
    Sakabe H; Ohmizono Y; Tanimukai S; Kimura T; Mori KJ; Abe T; Sonoda Y
    Stem Cells; 1997; 15(1):73-81. PubMed ID: 9007225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic and functional characterization of committed and primitive myeloid and lymphoid hematopoietic precursors in human fetal liver.
    Roy V; Miller JS; Verfaillie CM
    Exp Hematol; 1997 May; 25(5):387-94. PubMed ID: 9168060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic analysis of early hematopoietic progenitors in cord blood and determination of their correlation with clonogenic progenitors: relevance to cord blood stem cell transplantation.
    Payne TA; Traycoff CM; Laver J; Xu F; Srour EF; Abboud MR
    Bone Marrow Transplant; 1995 Feb; 15(2):187-92. PubMed ID: 7539665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
    Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of the expression of CD38 and human leukocyte antigen-DR on CD34+ hematopoietic progenitor cells by interleukin-4 and interferon-gamma.
    Snoeck HW; Lardon F; Lenjou M; Nys G; Van Bockstaele DR; Peetermans ME
    Exp Hematol; 1993 Oct; 21(11):1480-6. PubMed ID: 7691636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD34++ CD38- and CD34+ CD38+ human hematopoietic progenitors from fetal liver, cord blood, and adult bone marrow respond differently to hematopoietic cytokines depending on the ontogenic source.
    Weekx SF; Van Bockstaele DR; Plum J; Moulijn A; Rodrigus I; Lardon F; De Smedt M; Nijs G; Lenjou M; Loquet P; Berneman ZN; Snoeck HW
    Exp Hematol; 1998 Oct; 26(11):1034-42. PubMed ID: 9766443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of CD34-positive cells and subpopulations in human umbilical cord blood and bone marrow.
    Kinniburgh D; Russell NH
    Bone Marrow Transplant; 1993 Nov; 12(5):489-94. PubMed ID: 7507766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High efficiency electroporation of human umbilical cord blood CD34+ hematopoietic precursor cells.
    Wu MH; Smith SL; Dolan ME
    Stem Cells; 2001; 19(6):492-9. PubMed ID: 11713340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of hemopoietic cell populations from human cord blood expressing c-kit.
    Reisbach G; Bartke I; Kempkes B; Kostka G; Ellwart J; Birner A; Thalmeier K; Mailhammer R; Bornkamm GW; Ullrich A
    Exp Hematol; 1993 Jan; 21(1):74-9. PubMed ID: 7678090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the coexpression of CD38, CD33 and HLA-DR antigens on CD34+ purified cells from human cord blood and bone marrow.
    De Bruyn C; Delforge A; Bron D; Bernier M; Massy M; Ley P; de Hemptinne D; Stryckmans P
    Stem Cells; 1995 May; 13(3):281-8. PubMed ID: 7613494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between IL-3 receptor expression and growth potential of human CD34+ hematopoietic cells from different tissues.
    Huang S; Chen Z; Yu JF; Young D; Bashey A; Ho AD; Law P
    Stem Cells; 1999; 17(5):265-72. PubMed ID: 10527461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of peripheral blood progenitor cells mobilized by nartograstim (N-terminal replaced granulocyte colony-stimulating factor) in normal volunteers.
    Maruyama K; Tsuji K; Tanaka R; Yamada K; Kodera Y; Nakahata T
    Bone Marrow Transplant; 1998 Aug; 22(4):313-20. PubMed ID: 9722064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human CD34(+) and CD34(+)CD38(-) hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cells.
    Luck L; Zeng L; Hiti AL; Weinberg KI; Malik P
    Exp Hematol; 2004 May; 32(5):483-93. PubMed ID: 15145217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel protocol that allows short-term stem cell expansion of both committed and pluripotent hematopoietic progenitor cells suitable for clinical use.
    Astori G; Malangone W; Adami V; Risso A; Dorotea L; Falasca E; Marini L; Spizzo R; Bigi L; Sala P; Tonutti E; Biffoni F; Rinaldi C; Del Frate G; Pittino M; Degrassi A
    Blood Cells Mol Dis; 2001; 27(4):715-24; discussion 725-7. PubMed ID: 11778655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro growth and quantification of early (CD33-/CD38-) myeloid progenitor cells: stem cell factor requirement and effects of previous chemotherapy.
    Ferrero D; Cherasco C; Ortolano B; Giaretta F; Bruno B
    Haematologica; 1999 May; 84(5):390-6. PubMed ID: 10329916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.